UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Ajou research team gets Gates Foundation’s fund to provide Covid-19 data
by Kim Yoon-mi
2020-04-22 14:34
Covid-19 related myocarditis in 21-year-old reported in Korea
by Kim Yoon-mi
2020-04-20 12:58
AI model developed to predict survival in prostate cancer patients
by Kim Yoon-mi
2020-04-14 11:33
‘Robotic surgery better than laparoscope operation in gastric cancer’
by Kim Yoon-mi
2020-04-13 16:03
Myongji Hospital leads Korea’s fight against COVID-19
by Kim Yoon-mi
2020-04-13 10:31
라인
Immunologic classification predicts effect of immunotherapies in OPC
by Kim Yoon-mi
2020-04-09 16:35
Plasma therapy cures 2 severe COVID-19 patients in Korea
by Kim Yoon-mi
2020-04-07 18:17
‘Hepatitis B patients can stop antiviral drug if surface antigen disappears’
by Kim Yoon-mi
2020-04-06 15:32
School closure prevented at least 200 cases in Korea: study
by Kim Yoon-mi
2020-04-06 11:21
‘Cheap ventilators long been available in Korea’
by Kim Yoon-mi
2020-04-03 15:35
라인
1st COVID-19 death of doctor reported in Korea
by Kim Yoon-mi
2020-04-03 11:42
Venclexta extended survival in first-line acute myeloid leukemia
by Kim Yoon-mi
2020-04-02 15:31
Korea to spend ₩215.1 billion on vaccine research
by Kim Yoon-mi
2020-04-02 15:10
‘Community treatment centers save medical resources in pandemic’
by Kim Yoon-mi
2020-04-01 14:47
-
1
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top